Home NDC 80432-053 NDC 80432-053 - Lidocaine and Prilocaine Cream This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 80432-053
Package NDCs from labels 80432-053-65, 80432-053-71
Manufacturer TriRx Huntsville Pharmaceutical Services
Effective date 2024-06-03
Current FDA listing Not matched in FDA.report NDC product tables
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 38 of 54 · 1,077 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Pain Reliveing Patch LIDOCAINE 4% simple diagnostics 02ed0b27-bba9-ec0c-e063-6294a90a014d 2025-02-07 Warnings Exact identifier unii: 98PI200987 Bestmade Natural Products BM63 CEANOTHUS, KALI MUR, KALI ARS, OOPHRINUM, SELENIUM, THALLIUM, WEISBADEN Bestmade Natural Products 2cea4552-3700-3da3-e063-6294a90a14b5 2025-01-30 Warnings Exact identifier unii: 059QF0KO0R Lidocaine Pain Relieving Gel-Patch LIDOCAINE 4% Noble OTC LLC 12a3ce63-6fce-0993-e063-6294a90a40d5 2025-01-28 Warnings Exact identifier unii: 98PI200987 lidocaine LIDOCAINE Nivagen Pharmaceuticals, Inc. 32964ec3-1880-477b-9f71-2222c39106aa 2025-01-23 Warnings Exact identifier unii: 98PI200987 Lidocaine LIDOCAINE Direct_Rx fd8a640a-b5ca-f0a7-e053-6394a90ad603 2025-01-22 Warnings, Adverse reactions Exact identifier unii: 98PI200987 Lidocaine LIDOCAINE Direct_Rx feb8692a-9c08-0d5c-e053-6394a90a904b 2025-01-22 Warnings, Adverse reactions Exact identifier unii: 98PI200987 LIDOCAINE LIDOCAINE PHARMACURE LLC 53384c51-6da1-4fa4-8782-2606ca3d1c6f 2025-01-22 Warnings Exact identifier unii: 98PI200987 FORTHiQ Pain Relief Lidocaine Patch PAIN RELIEF LIDOCAINE PATCH Henan Enokon Medical Instrument Co., Ltd. 2c593420-5788-3422-e063-6394a90a1890 2025-01-22 Warnings Exact identifier unii: 98PI200987 Care Science LIDOCAINE ASO LLC 2c399fec-bce7-2a41-e063-6294a90a0e73 2025-01-21 Warnings Exact identifier unii: 98PI200987 RETALIEF LIDOCAINE 5 LIDOCAINE Reliable 1 Laboratories LLC 2c262f3c-8cb2-4384-e063-6294a90a436d 2025-01-20 Warnings Exact identifier unii: 98PI200987 Medics Choice Soothing Eye Wash PURIFIED WATER KC Pharmaceuticals, Inc. 10e49808-161e-f4ec-e063-6294a90a1775 2025-01-19 Warnings Exact identifier unii: 059QF0KO0R Curist Lidocaine Patch Maximum Strength LIDOCAINE Little Pharma, Inc. e574c188-cc65-287d-e053-2995a90a5972 2025-01-16 Warnings Exact identifier unii: 98PI200987 Lidocaine Pain Relief Gel-Patch LIDOCAINE Guangzhou Zhupuyou E-commerce Co., Ltd 296fcc36-563f-19ca-e063-6394a90ab3ae 2025-01-15 Warnings Exact identifier unii: 98PI200987 Anecream LIDOCAINE 4% Focus Health Group 2d7706e2-7363-4047-96cb-85b718277e8c 2025-01-15 Warnings Exact identifier unii: 98PI200987 Anecream 5 LIDOCAINE 5% Focus Health Group 1810edc3-093e-402f-bcb0-9c731da283a7 2025-01-15 Warnings Exact identifier unii: 98PI200987 Pain Relief Patch 4% Lidocaine LIDOCAINE Reliable 1 Laboratories LLC 2b624763-c310-63d9-e063-6394a90a1928 2025-01-15 Warnings Exact identifier unii: 98PI200987 Jakwork Numbing Cream NUMBING CREAM Guangzhou Zanming Trading Co., Ltd. 2ba1de83-494a-6c54-e063-6294a90a9b2d 2025-01-13 Warnings Exact identifier unii: 98PI200987 Re-Lieved Lidocaine Patch LIDOCAINE PATCH 4% Transfer Technology 00b40dda-53ad-0458-e063-6394a90aa835 2025-01-11 Warnings Exact identifier unii: 98PI200987 Re-Lieved Lidocaine Patch LIDOCAINE PATCH 4% Transfer Technology 00b47eb7-6b43-d9e2-e063-6294a90a9a38 2025-01-11 Warnings Exact identifier unii: 98PI200987 Re-Lieved 4% Lidocaine Fabric Tape LIDOCAINE 4% FABRIC TAPE Transfer Technology e9a894b0-54f2-707e-e053-2a95a90a0f0d 2025-01-11 Warnings Exact identifier unii: 98PI200987
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.